1. A biostatistical model for identifying risk factors for chronic diseases, comprising: a machine learning component configured to process and analyze medical records, genetic information, and lifestyle factors; a statistical analysis component configured to identify significant associations and interactions between the analyzed data and chronic diseases; a data mining component configured to extract relevant information from large-scale datasets for further analysis; and an output component configured to generate a risk prediction report for individuals based on the identified risk factors.

2. The biostatistical model of claim 1, wherein the machine learning component comprises one or more of the following algorithms: logistic regression, support vector machines, decision trees, random forests, deep learning, and neural networks.

3. The biostatistical model of claim 1, wherein the statistical analysis component utilizes methods including but not limited to linear regression, multivariate regression, principal component analysis, and factor analysis to assess the relationships between risk factors and chronic diseases.

4. The biostatistical model of claim 1, wherein the data mining component employs techniques such as association rule mining, clustering, and classification to identify patterns and trends in the data.

5. The biostatistical model of claim 1, wherein the output component generates a risk prediction report that includes a quantitative estimation of an individual's susceptibility to a specific chronic disease, as well as personalized recommendations for lifestyle modifications and preventive measures.

6. A method for identifying risk factors for chronic diseases using the biostatistical model of claim 1, comprising the steps of: collecting data from various sources, including medical records, genetic information, and lifestyle factors; preprocessing the collected data to remove noise, missing values, and inconsistencies; inputting the preprocessed data into the machine learning component for analysis; applying statistical methods to identify significant relationships between the analyzed data and chronic diseases; utilizing data mining techniques to extract further information from large-scale datasets; and generating a risk prediction report based on the identified risk factors and individual susceptibility to chronic diseases.

7. The method of claim 6, further comprising the step of validating the biostatistical model's predictions using a holdout validation set or cross-validation techniques to ensure the accuracy and reliability of the model.

8. The method of claim 6, further comprising the step of updating the biostatistical model periodically with new data and research findings to improve the accuracy and relevance of its predictions. Biostatistical Model for Identifying Risk Factors for Chronic Diseases Abstract The biostatistical model presented in this patent identifies risk factors for chronic diseases through the processing and analysis of medical records, genetic information, and lifestyle factors. It includes a machine learning component, statistical analysis component, data mining component, and output component, which work together to generate a risk prediction report for individuals. The model uses algorithms such as logistic regression, support vector machines, and deep learning to analyze the data, and statistical methods like linear regression and principal component analysis to identify significant relationships. The data mining component employs association rule mining, clustering, and classification techniques to extract further information. The output component generates a risk prediction report that includes personalized recommendations. The method for identifying risk factors includes preprocessing the data, analyzing it with the model, and generating a risk prediction report. The model's accuracy and relevance are ensured through holdout validation or cross-validation techniques, and it is periodically updated with new data and research findings. , Claims:Claims :

1. A biostatistical model for identifying risk factors for chronic diseases, comprising: a machine learning component configured to process and analyze medical records, genetic information, and lifestyle factors; a statistical analysis component configured to identify significant associations and interactions between the analyzed data and chronic diseases; a data mining component configured to extract relevant information from large-scale datasets for further analysis; and an output component configured to generate a risk prediction report for individuals based on the identified risk factors.

2. The biostatistical model of claim 1, wherein the machine learning component comprises one or more of the following algorithms: logistic regression, support vector machines, decision trees, random forests, deep learning, and neural networks.

3. The biostatistical model of claim 1, wherein the statistical analysis component utilizes methods including but not limited to linear regression, multivariate regression, principal component analysis, and factor analysis to assess the relationships between risk factors and chronic diseases.

4. The biostatistical model of claim 1, wherein the data mining component employs techniques such as association rule mining, clustering, and classification to identify patterns and trends in the data.

5. The biostatistical model of claim 1, wherein the output component generates a risk prediction report that includes a quantitative estimation of an individual's susceptibility to a specific chronic disease, as well as personalized recommendations for lifestyle modifications and preventive measures.

6. A method for identifying risk factors for chronic diseases using the biostatistical model of claim 1, comprising the steps of: collecting data from various sources, including medical records, genetic information, and lifestyle factors; preprocessing the collected data to remove noise, missing values, and inconsistencies; inputting the preprocessed data into the machine learning component for analysis; applying statistical methods to identify significant relationships between the analyzed data and chronic diseases; utilizing data mining techniques to extract further information from large-scale datasets; and generating a risk prediction report based on the identified risk factors and individual susceptibility to chronic diseases.

7. The method of claim 6, further comprising the step of validating the biostatistical model's predictions using a holdout validation set or cross-validation techniques to ensure the accuracy and reliability of the model.

8. The method of claim 6, further comprising the step of updating the biostatistical model periodically with new data and research findings to improve the accuracy and relevance of its predictions.

Description:Biostatistical Model for Identifying Risk Factors for Chronic Diseases
Field of the Invention
[0001] The present invention relates to the field of biostatistics and personalized medicine. In particular, the invention relates to a biostatistical model for identifying risk factors for chronic diseases based on genomic data, environmental data, and clinical data.
Background
[0002] The background description includes information that may be useful in understanding the present invention. It is not an admission that any of the information provided herein is prior art or relevant to the presently claimed invention, or that any publication specifically or implicitly referenced is prior art.
[0003] Chronic diseases, such as heart disease, diabetes, and cancer, are a major public health concern worldwide, as they are the leading cause of death and disability in many countries. Identifying risk factors for these diseases is essential for developing effective prevention and treatment strategies. Risk factors refer to any characteristic, behavior, or environmental exposure that increases an individual's likelihood of developing a particular disease.
[0004] Biostatistical modeling techniques have been widely used in epidemiology to identify risk factors for chronic diseases. These models typically involve analyzing large datasets of health and demographic information to identify factors associated with increased disease risk. Biostatistical models can identify risk factors that are not easily identified through observational studies or clinical trials, and can help identify subpopulations that may be at higher risk for certain diseases.
[0005] However, these biostatistical models also have limitations. One limitation is that they may be limited to analyzing only a small number of risk factors due to computational or data availability constraints. Additionally, these models may not fully account for the complex interactions between multiple risk factors. For example, a person's genetic makeup, lifestyle factors, and environmental exposures may interact in complex ways to influence their risk of developing a chronic disease.
[0006] Therefore, there is a need for an improved biostatistical model that can more accurately identify risk factors for chronic diseases, including their complex interactions. Such a model would enable better targeting of prevention and treatment strategies, leading to improved health outcomes for individuals and populations. By developing a more comprehensive understanding of the risk factors associated with chronic diseases, public health officials, clinicians, and researchers can better allocate resources and develop more effective interventions.
[0007] All references, including publications, patent applications, and patents, cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.
[0008] It also shall be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise. This invention can be achieved by means of hardware including several different elements or by means of a suitably programmed computer. In the unit claims that list several means, several ones among these means can be specifically embodied in the same hardware item. The use of such words as first, second, third does not represent any order, which can be simply explained as names.
Summary
[0009] Various objects, features, and advantages of the disclosed subject matter can be more fully appreciated with reference to the following detailed description of the disclosed subject matter when considered in connection with the following drawings, in which like reference numerals identify like elements.
[00010] The present invention relates to the field of biostatistics and personalized medicine. In particular, the invention relates to a biostatistical model for identifying risk factors for chronic diseases based on genomic data, environmental data, and clinical data.
[00011] The biostatistical model described in this patent is designed to identify risk factors for chronic diseases by processing and analyzing medical records, genetic information, and lifestyle factors. The model comprises four main components: a machine learning component, statistical analysis component, data mining component, and output component.
[00012] The machine learning component of the model uses algorithms such as logistic regression, support vector machines, decision trees, random forests, deep learning, and neural networks to process and analyze the input data. The statistical analysis component utilizes methods like linear regression, multivariate regression, principal component analysis, and factor analysis to identify significant associations and interactions between the analyzed data and chronic diseases. The data mining component employs techniques such as association rule mining, clustering, and classification to extract relevant information from large-scale datasets for further analysis. Finally, the output component generates a risk prediction report for individuals based on the identified risk factors.
[00013] The risk prediction report generated by the model includes a quantitative estimation of an individual's susceptibility to a specific chronic disease, as well as personalized recommendations for lifestyle modifications and preventive measures. This report can be used by healthcare professionals to provide personalized treatment plans and recommendations for their patients.
[00014] The method for identifying risk factors for chronic diseases using the biostatistical model involves collecting data from various sources, including medical records, genetic information, and lifestyle factors. The collected data is then preprocessed to remove noise, missing values, and inconsistencies before being inputted into the machine learning component for analysis. Statistical methods are applied to identify significant relationships between the analyzed data and chronic diseases, and data mining techniques are used to extract further information from large-scale datasets. Finally, a risk prediction report is generated based on the identified risk factors and an individual's susceptibility to chronic diseases.
[00015] To ensure the accuracy and reliability of the model's predictions, the method also involves validating the biostatistical model's predictions using a holdout validation set or cross-validation techniques. Additionally, the model is periodically updated with new data and research findings to improve the accuracy and relevance of its predictions.
[00016] In summary, the biostatistical model and method presented in this patent can provide healthcare professionals with a powerful tool for identifying risk factors for chronic diseases and providing personalized treatment plans and recommendations. By leveraging machine learning, statistical analysis, and data mining techniques, the model can provide accurate and relevant predictions that can improve patient outcomes and help reduce healthcare costs.
Brief Description of the Drawings
[00017] The features and advantages of the present disclosure would be more clearly understood from the following description taken in conjunction with the accompanying drawings in which:
[00018] FIG. 1 denotes a representative system identifying risk factors for chronic diseases, according to some embodiments of the present disclosure.
[00019] FIG. 2 shows an exemplary flowchart exemplifying a method recognizing risk factors for persistance disorder, according to some embodiments of the present disclosure.
Detailed Description
[00020] The following is a detailed description of exemplary embodiments to illustrate the principles of the invention. The embodiments are provided to illustrate aspects of the invention, but the invention is not limited to any embodiment. The scope of the invention encompasses numerous alternatives, modifications and equivalent; it is limited only by the claims.
[00021] In view of the many possible embodiments to which the principles of the present discussion may be applied, it should be recognized that the embodiments described herein with respect to the drawing figures are meant to be illustrative only and should not be taken as limiting the scope of the claims. Therefore, the techniques as described herein contemplate all such embodiments as may come within the scope of the following claims and equivalents thereof.
[00022] Throughout the present disclosure, the term “network” relates to an arrangement of interconnected programmable and/or non-programmable components that are configured to facilitate data communication between one or more electronic devices and/or databases, whether available or known at the time of filing or as later developed. Furthermore, the network may include, but is not limited to, one or more peer-to-peer network, a hybrid peer-to-peer network, local area networks (LANs), radio access networks (RANs), metropolitan area networks (MANS), wide area networks (WANs), all or a portion of a public network such as the global computer network known as the Internet, a private network, a cellular network and any other communication system or systems at one or more locations.
[00023] Throughout the present disclosure, the term “process”* relates to any collection or set of instructions executable by a computer or other digital system so as to configure the computer or the digital system to perform a task that is the intent of the process.
[00024] Throughout the present disclosure, the term ‘Artificial intelligence (AI)’ as used herein relates to any mechanism or computationally intelligent system that combines knowledge, techniques, and methodologies for controlling a bot or other element within a computing environment. Furthermore, the artificial intelligence (AI) is configured to apply knowledge and that can adapt it-self and learn to do better in changing environments. Additionally, employing any computationally intelligent technique, the artificial intelligence (AI) is operable to adapt to unknown or changing environment for better performance. The artificial intelligence (AI) includes fuzzy logic engines, decision-making engines, preset targeting accuracy levels, and/or programmatically intelligent software.
[00025] The detailed description is described with reference to the accompanying figures. In the figures, the left-most digit(s) of a reference number identifies the figure in which the reference number first appears. The use of the same reference numbers in different instances in the description and the figures may indicate similar or identical items.
[00026] The present invention relates to the field of biostatistics and personalized medicine. In particular, the invention relates to a biostatistical model for identifying risk factors for chronic diseases based on genomic data, environmental data, and clinical data.
[00027] The present invention relates to a biostatistical model 100 for identifying risk factors for chronic diseases. The model comprises four main components: a machine learning component 102, a statistical analysis component 104, a data mining component 106, and an output component 108. These components work in tandem to analyze medical records, genetic information, and lifestyle factors, identify significant associations and interactions between the analyzed data and chronic diseases, extract relevant information from large-scale datasets, and generate a risk prediction report for individuals based on the identified risk factors.
[00028] In one embodiment, the machine learning component of the biostatistical model is configured to process and analyze medical records, genetic information, and lifestyle factors. The component employs various machine learning algorithms, such as logistic regression, support vector machines, decision trees, random forests, deep learning, and neural networks. These algorithms enable the model to learn from the data, identify complex patterns, and make predictions about an individual's susceptibility to chronic diseases.
[00029] The machine learning component preprocesses the data to remove noise, missing values, and inconsistencies. It then normalizes and transforms the data to ensure that it can be effectively used in the analysis. Feature selection techniques, such as LASSO or stepwise regression, may be employed to identify the most relevant variables for the prediction task.
[00030] In another embodiment, the statistical analysis component of the biostatistical model is configured to identify significant associations and interactions between the analyzed data and chronic diseases. This component employs various statistical methods, including linear regression, multivariate regression, principal component analysis, and factor analysis. These methods help the model assess the relationships between risk factors and chronic diseases, quantify the strength of these relationships, and identify potential confounding factors.
[00031] By identifying significant associations and interactions, the statistical analysis component can help determine which variables contribute the most to an individual's risk of developing a chronic disease. This information can then be used to generate personalized recommendations for lifestyle modifications and preventive measures.
[00032] In yet another embodiment, the data mining component of the biostatistical model is configured to extract relevant information from large-scale datasets for further analysis. The component employs techniques such as association rule mining, clustering, and classification to identify patterns and trends in the data. This information can then be used to refine the model's predictions and generate more accurate risk assessments.
[00033] For example, the data mining component might identify clusters of individuals with similar genetic profiles or lifestyle habits who are at an increased risk of developing a specific chronic disease. This information can be used to target interventions or preventive measures more effectively and efficiently.
[00034] In a further embodiment, the output component of the biostatistical model is configured to generate a risk prediction report for individuals based on the identified risk factors. The report includes a quantitative estimation of an individual's susceptibility to a specific chronic disease, as well as personalized recommendations for lifestyle modifications and preventive measures.
[00035] The risk prediction report may also include visualizations, such as heatmaps or bar charts, to help individuals better understand their risk factors and the potential impact of different interventions. The report can be shared with healthcare professionals to facilitate informed decision-making and promote better health outcomes.
[00036] In some embodiments, the biostatistical model may be implemented as a web-based application, a mobile app, or integrated into electronic health record systems. This would allow for seamless integration into existing healthcare workflows and easy access for both individuals and healthcare professionals.
[00037] prediction report that includes a quantitative estimation of an individual's susceptibility to a specific chronic disease, as well as personalized recommendations for lifestyle modifications and preventive measures.
[00038] The present invention provides a biostatistical model for identifying risk factors for chronic diseases. The model comprises a machine learning component that can utilize one or more of the following algorithms: logistic regression, support vector machines, decision trees, random forests, deep learning, and neural networks. The statistical analysis component uses methods including but not limited to linear regression, multivariate regression, principal component analysis, and factor analysis to assess the relationships between risk factors and chronic diseases. The data mining component employs techniques such as association rule mining, clustering, and classification to identify patterns and trends in the data.
[00039] The biostatistical model can be used to generate a risk prediction report that includes a quantitative estimation of an individual's susceptibility to a specific chronic disease, as well as personalized recommendations for lifestyle modifications and preventive measures. The output component can also provide a visualization of the data, such as a dashboard or graphs, to facilitate data analysis and interpretation.
[00040] An exemplary use case for the biostatistical model could be in a clinical setting where a patient's data, including genomic data, environmental data, and clinical data, is collected and analyzed using the model. The machine learning component could identify patterns and risk factors in the data, while the statistical analysis component could assess the relationships between the risk factors and chronic diseases. The data mining component could then further identify patterns and trends in the data, potentially leading to new insights into disease prevention and management.
[00041] The risk prediction report generated by the model could provide personalized recommendations for lifestyle modifications and preventive measures, such as dietary changes, exercise regimens, and screening tests. This could help healthcare professionals to better manage chronic diseases, potentially leading to improved health outcomes for patients.
[00042] An exemplary use case scenario for the biostatistical model could be in a healthcare setting, where a primary care physician or a specialist uses the model to assess a patient's risk for developing a chronic disease such as diabetes, heart disease, or cancer.
[00043] The physician inputs the patient's medical records, genetic information, and lifestyle factors into the machine learning component of the model. The machine learning algorithms process and analyze this information to identify patterns and associations that could increase the patient's risk of developing a chronic disease.
[00044] The statistical analysis component of the model is then used to identify significant associations and interactions between the analyzed data and chronic diseases. This allows the physician to identify the specific risk factors that are most relevant to the patient's situation.
[00045] The data mining component of the model is used to extract relevant information from large-scale datasets for further analysis. This allows the physician to compare the patient's data with data from other patients with similar risk factors and identify any additional risk factors that may have been overlooked.
[00046] Finally, the output component generates a risk prediction report for the patient based on the identified risk factors. The report provides the patient with a quantitative estimation of their susceptibility to a specific chronic disease, as well as personalized recommendations for lifestyle modifications and preventive measures.
[00047] Based on the risk prediction report, the physician can work with the patient to develop a personalized plan for managing their risk factors and preventing the onset of chronic diseases. This could include changes to the patient's diet, exercise routine, and medication regimen. By identifying and managing risk factors early, the biostatistical model can help to prevent or delay the onset of chronic diseases, leading to improved health outcomes for patients.
[00048] The method 200 for identifying risk factors for chronic diseases using the biostatistical model begins with collecting data from various sources, including medical records, genetic information, and lifestyle factors, at step 202. This data may be collected from electronic health records, surveys, or wearable devices. Once the data has been collected, it is preprocessed to remove noise, missing values, and inconsistencies, at step 204. This involves cleaning and standardizing the data to ensure that it is accurate and usable. The preprocessed data is then input into the machine learning component of the biostatistical model for analysis. At step 206, the machine learning component of the model uses algorithms such as logistic regression, support vector machines, decision trees, random forests, deep learning, and neural networks to analyze the data and identify patterns and associations that could increase the risk of developing chronic diseases. At step 208, the statistical analysis component of the model is then applied to identify significant relationships between the analyzed data and chronic diseases. This component utilizes methods including linear regression, multivariate regression, principal component analysis, and factor analysis to assess the relationships between risk factors and chronic diseases. At step 210, the data mining component of the model is employed to extract further information from large-scale datasets. This component uses techniques such as association rule mining, clustering, and classification to identify patterns and trends in the data. At step 212, the output component generates a risk prediction report based on the identified risk factors and individual susceptibility to chronic diseases. The report provides a quantitative estimation of an individual's susceptibility to a specific chronic disease, as well as personalized recommendations for lifestyle modifications and preventive measures.
[00049] In an embodiment, the method involves using a biostatistical model to predict the likelihood of a certain health outcome or disease based on a set of variables. To ensure the accuracy and reliability of these predictions, it is important to validate the model's performance using holdout validation or cross-validation techniques.
[00050] Holdout validation involves dividing the data into two sets: a training set, which is used to train the model, and a holdout set, which is used to test the model's predictions. The holdout set is not used during the training phase, and it serves as an independent sample to evaluate the model's performance.
[00051] Cross-validation, on the other hand, involves dividing the data into several subsets, or "folds," and using each fold in turn as a validation set while the remaining folds are used to train the model. This technique can help to reduce overfitting, which occurs when a model is too complex and performs well on the training data but poorly on new data.
[00052] By using either holdout validation or cross-validation techniques, the accuracy and reliability of the biostatistical model can be evaluated and improved as necessary. If the model performs poorly on the validation set, adjustments can be made to improve its performance.
[00053] In addition to validating the model's predictions, the method also involves periodically updating the biostatistical model with new data and research findings to ensure its accuracy and relevance. As new data becomes available, the model can be retrained using the updated data to improve its predictions. This allows the model to stay current with the latest research and to continue providing accurate and relevant predictions.
[00054] The above description is intended to be illustrative, and not restrictive. Although the present disclosure has been described with references to specific illustrative examples and implementations, it will be recognized that the present disclosure is not limited to the examples and implementations described. The scope of the disclosure should be determined with reference to the following claims, along with the full scope of equivalents to which the claims are entitled.
[00055] Modifications, additions, or omissions may be made to the systems and apparatuses described herein without departing from the scope of the disclosure. The components of the systems and apparatuses may be integrated or separated. Moreover, the operations of the systems and apparatuses may be performed by more, fewer, or other components. Additionally, operations of the systems and apparatuses may be performed using any suitable logic comprising software, hardware, and/or other logic. As used in this document, “each” refers to each member of a set or each member of a subset of a set.
[00056] The term “memory,” as used herein relates to a volatile or persistent medium, such as a magnetic disk, or optical disk, in which a computer can store data or software for any duration. Optionally, the memory is non-volatile mass storage such as physical storage media. Furthermore, a single memory may encompass and in a scenario wherein computing system is distributed, the processing, memory and/or storage capability may be distributed as well.
[00057] Throughout the present disclosure, the term ‘server’ relates to a structure and/or module that include programmable and/or non-programmable components configured to store, process and/or share information. Optionally, the server includes any arrangement of physical or virtual computational entities capable of enhancing information to perform various computational tasks.

 

Claims
I/We Claim:
1. A biostatistical model for identifying risk factors for chronic diseases, comprising: a machine learning component configured to process and analyze medical records, genetic information, and lifestyle factors; a statistical analysis component configured to identify significant associations and interactions between the analyzed data and chronic diseases; a data mining component configured to extract relevant information from large-scale datasets for further analysis; and an output component configured to generate a risk prediction report for individuals based on the identified risk factors.

2. The biostatistical model of claim 1, wherein the machine learning component comprises one or more of the following algorithms: logistic regression, support vector machines, decision trees, random forests, deep learning, and neural networks.

3. The biostatistical model of claim 1, wherein the statistical analysis component utilizes methods including but not limited to linear regression, multivariate regression, principal component analysis, and factor analysis to assess the relationships between risk factors and chronic diseases.
4. The biostatistical model of claim 1, wherein the data mining component employs techniques such as association rule mining, clustering, and classification to identify patterns and trends in the data.

5. The biostatistical model of claim 1, wherein the output component generates a risk prediction report that includes a quantitative estimation of an individual's susceptibility to a specific chronic disease, as well as personalized recommendations for lifestyle modifications and preventive measures.

6. A method for identifying risk factors for chronic diseases using the biostatistical model of claim 1, comprising the steps of: collecting data from various sources, including medical records, genetic information, and lifestyle factors; preprocessing the collected data to remove noise, missing values, and inconsistencies; inputting the preprocessed data into the machine learning component for analysis; applying statistical methods to identify significant relationships between the analyzed data and chronic diseases; utilizing data mining techniques to extract further information from large-scale datasets; and generating a risk prediction report based on the identified risk factors and individual susceptibility to chronic diseases.

7. The method of claim 6, further comprising the step of validating the biostatistical model's predictions using a holdout validation set or cross-validation techniques to ensure the accuracy and reliability of the model.

8. The method of claim 6, further comprising the step of updating the biostatistical model periodically with new data and research findings to improve the accuracy and relevance of its predictions.

Biostatistical Model for Identifying Risk Factors for Chronic Diseases
Abstract
The biostatistical model presented in this patent identifies risk factors for chronic diseases through the processing and analysis of medical records, genetic information, and lifestyle factors. It includes a machine learning component, statistical analysis component, data mining component, and output component, which work together to generate a risk prediction report for individuals. The model uses algorithms such as logistic regression, support vector machines, and deep learning to analyze the data, and statistical methods like linear regression and principal component analysis to identify significant relationships. The data mining component employs association rule mining, clustering, and classification techniques to extract further information. The output component generates a risk prediction report that includes personalized recommendations. The method for identifying risk factors includes preprocessing the data, analyzing it with the model, and generating a risk prediction report. The model's accuracy and relevance are ensured through holdout validation or cross-validation techniques, and it is periodically updated with new data and research findings. , Claims:Claims
I/We Claim:
1. A biostatistical model for identifying risk factors for chronic diseases, comprising: a machine learning component configured to process and analyze medical records, genetic information, and lifestyle factors; a statistical analysis component configured to identify significant associations and interactions between the analyzed data and chronic diseases; a data mining component configured to extract relevant information from large-scale datasets for further analysis; and an output component configured to generate a risk prediction report for individuals based on the identified risk factors.

2. The biostatistical model of claim 1, wherein the machine learning component comprises one or more of the following algorithms: logistic regression, support vector machines, decision trees, random forests, deep learning, and neural networks.

3. The biostatistical model of claim 1, wherein the statistical analysis component utilizes methods including but not limited to linear regression, multivariate regression, principal component analysis, and factor analysis to assess the relationships between risk factors and chronic diseases.
4. The biostatistical model of claim 1, wherein the data mining component employs techniques such as association rule mining, clustering, and classification to identify patterns and trends in the data.

5. The biostatistical model of claim 1, wherein the output component generates a risk prediction report that includes a quantitative estimation of an individual's susceptibility to a specific chronic disease, as well as personalized recommendations for lifestyle modifications and preventive measures.

6. A method for identifying risk factors for chronic diseases using the biostatistical model of claim 1, comprising the steps of: collecting data from various sources, including medical records, genetic information, and lifestyle factors; preprocessing the collected data to remove noise, missing values, and inconsistencies; inputting the preprocessed data into the machine learning component for analysis; applying statistical methods to identify significant relationships between the analyzed data and chronic diseases; utilizing data mining techniques to extract further information from large-scale datasets; and generating a risk prediction report based on the identified risk factors and individual susceptibility to chronic diseases.

7. The method of claim 6, further comprising the step of validating the biostatistical model's predictions using a holdout validation set or cross-validation techniques to ensure the accuracy and reliability of the model.

8. The method of claim 6, further comprising the step of updating the biostatistical model periodically with new data and research findings to improve the accuracy and relevance of its predictions.